Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEro_PLASma Trial in small infants undergoing cardiac surgery
2018-004068-74Phase 2Completed
- Sponsor
- Policlinico San Donato
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of Fibrinogen human and prothrombin complex concentrate, human in Cardiovascular Malformation (CVM) and cardiac disease (2 arms), sponsored by Policlinico San Donato. Primary endpoint: Feasibility of avoiding fresh frozen plasma. Started Dec 2020; status: completed.
02
Drugs
Fibrinogen humanprothrombin complex concentrate, human
03
Conditions
Cardiovascular Malformation (CVM)cardiac disease
Beyond the preview
Go deeper on 2018-004068-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004068-74.